Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01583673 · ClinicalTrials.gov registry record · NA
Growth of Infants Fed an Amino Acid Infant Formula
A NA study, sponsored by Société des Produits Nestlé (SPN).
- Completed
- Registry status
- NA
- Development phase
- 225
- Enrollment target
NCT01583673 is a NA study that has completed, run by Société des Produits Nestlé (SPN). The registered enrollment target is 225 participants.
The verdict
NCT01583673, a NA study, has completed, sponsored by Société des Produits Nestlé (SPN).
- COMPLETED
- Registry status
- NA
- Development phase
- 225 participants
- Enrollment target
Study Summary
The primary objective of the clinical trial is to compare growth in infants (expressed as weight gain in g/day) consuming a new Amino Acid Formula to infants consuming a commercially available hypoallergenic formula over a period of 4 months.
Interventions
- OTHER Amino Acid Formula
- OTHER Amino Acid formula
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 225 participants |
| Start Date | 2012-05 |
| Est. Completion | 2013-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01583673
The ClinicalTrials.gov registry entry for NCT01583673 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 225 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Société des Produits Nestlé (SPN), which has 53 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Amino Acid Formula is the first listed.
NCT01583673 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01583673 about?
NCT01583673 is a clinical study titled "Growth of Infants Fed an Amino Acid Infant Formula". The primary objective of the clinical trial is to compare growth in infants (expressed as weight gain in g/day) consuming a new Amino Acid Formula to infants consuming a commercially available hypoallergenic formula over a period of 4 months.
What is the current status of trial NCT01583673?
This trial is currently completed. It is a NA study. The enrollment target is 225 participants. The study started on 2012-05. Estimated completion is 2013-07.
What interventions are being tested in trial NCT01583673?
The interventions under investigation include: Amino Acid Formula (OTHER), Amino Acid formula (OTHER).
Who is sponsoring clinical trial NCT01583673?
This trial is sponsored by Société des Produits Nestlé (SPN), which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.